Mangoceuticals (MGRX) Non-Current Assets (2022 - 2026)

Mangoceuticals' Non-Current Assets history runs 5 years deep, the most recent figure standing at $14.2 million for Q1 2026.

• In Q1 2026, Non-Current Assets fell 34.02% year-over-year to $14.2 million; the TTM figure through Mar 2026 stood at $14.2 million (down 34.02% YoY), while the FY2025 annual figure was $14.5 million, down 4.92% from the prior year.
• Non-Current Assets came in at $14.2 million for Q1 2026 at Mangoceuticals, down from $14.5 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $21.6 million in Q1 2025 to a low of $211639.0 in Q1 2024.
• A 5-year average of $9.5 million and a median of $14.4 million in 2025 frame the typical range for Non-Current Assets.
• Across the five-year window, Non-Current Assets soared 10095.29% in 2025 and slumped 34.02% in 2026, its largest moves.
• Mangoceuticals' Non-Current Assets stood at $308682.0 in 2022, then sank by 30.22% to $215391.0 in 2023, then surged by 7001.0% to $15.3 million in 2024, then dropped by 4.92% to $14.5 million in 2025, then retreated by 2.1% to $14.2 million in 2026.
• According to Business Quant data, Non-Current Assets over the past three periods registered $14.2 million, $14.5 million, and $15.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison